Literature DB >> 30425369

Be open about drug failures to speed up research.

Enrica Alteri, Lorenzo Guizzaro.   

Abstract

Keywords:  Alzheimer's disease; Medical research; Research data

Mesh：

Year:  2018        PMID： 30425369     DOI： 10.1038/d41586-018-07352-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health.

Authors:  J A Molzon; A Giaquinto; L Lindstrom; T Tominaga; M Ward; P Doerr; L Hunt; L Rago
Journal:  Clin Pharmacol Ther       Date:  2011-02-16       Impact factor: 6.875

Review 2.  Trends in risks associated with new drug development: success rates for investigational drugs.

Authors:  J A DiMasi; L Feldman; A Seckler; A Wilson
Journal:  Clin Pharmacol Ther       Date:  2010-02-03       Impact factor: 6.875

3.  Transparency and the European Medicines Agency--sharing of clinical trial data.

Authors:  Sergio Bonini; Hans-Georg Eichler; Noël Wathion; Guido Rasi
Journal:  N Engl J Med       Date:  2014-12-25       Impact factor: 91.245

4.  How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?

Authors:  Jared F Benge; Steve Balsis; Lisa Geraci; Paul J Massman; Rachelle S Doody
Journal:  Dement Geriatr Cogn Disord       Date:  2009-07-30       Impact factor: 2.959

Review 5.  Trials and Tribulations of CETP Inhibitors.

Authors:  Alan R Tall; Daniel J Rader
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

6.  Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors.

Authors:  Darren B Taichman; Peush Sahni; Anja Pinborg; Larry Peiperl; Christine Laine; Astrid James; Sung-Tae Hong; Abraham Haileamlak; Laragh Gollogly; Fiona Godlee; Frank A Frizelle; Fernando Florenzano; Jeffrey M Drazen; Howard Bauchner; Christopher Baethge; Joyce Backus
Journal:  Ann Intern Med       Date:  2017-06-06       Impact factor: 25.391
  6 in total
  11 in total

Review 1.  Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease.

Authors:  Xi-Bin Zhou; Yu-Xing Zhang; Chun-Xiang Zhou; Jun-Jie Ma
Journal:  Chin J Integr Med       Date:  2021-11-03       Impact factor: 1.978

Review 2.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

Review 3.  Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development.

Authors:  Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2021-03-11       Impact factor: 32.419

4.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

Review 5.  Bridging the academia-to-industry gap: organ-on-a-chip platforms for safety and toxicology assessment.

Authors:  Terry Ching; Yi-Chin Toh; Michinao Hashimoto; Yu Shrike Zhang
Journal:  Trends Pharmacol Sci       Date:  2021-06-27       Impact factor: 17.638

Review 6.  Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.

Authors:  Seiji Okada; Kulthida Vaeteewoottacharn; Ryusho Kariya
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

7.  AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.

Authors:  Yadi Zhou; Jiansong Fang; Lynn M Bekris; Young Heon Kim; Andrew A Pieper; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Alzheimers Res Ther       Date:  2021-01-13       Impact factor: 6.982

8.  Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.

Authors:  Jiansong Fang; Pengyue Zhang; Quan Wang; Chien-Wei Chiang; Yadi Zhou; Yuan Hou; Jielin Xu; Rui Chen; Bin Zhang; Stephen J Lewis; James B Leverenz; Andrew A Pieper; Bingshan Li; Lang Li; Jeffrey Cummings; Feixiong Cheng
Journal:  Alzheimers Res Ther       Date:  2022-01-10       Impact factor: 8.823

Review 9.  Harnessing preclinical models for the interrogation of ovarian cancer.

Authors:  Tianyu Qin; Junpeng Fan; Funian Lu; Li Zhang; Chen Liu; Qiyue Xiong; Yang Zhao; Gang Chen; Chaoyang Sun
Journal:  J Exp Clin Cancer Res       Date:  2022-09-16

10.  Ideation and implementation of an open science drug discovery business model - M4K Pharma.

Authors:  Maxwell Robert Morgan; Owen Gwilym Roberts; Aled Morgan Edwards
Journal:  Wellcome Open Res       Date:  2018-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.